MITF and melanoma: Finally, the AM404 + GSK126 combination, after O/N treatment, reversed the EMT-like profile of melanoma cells by reducing SNAIL, ZEB1, AXL, and α-catulin protein expression while upregulating MITF and E-cadherin (Supplementary Fig. S20a).